Corporate critical
illness.

A personal policy pays the capital to the insured person for their personal needs. A corporate policy pays the capital to the company to protect operations. The two can coexist and complement each other. Alexandre analyzes which combination matches your situation.

A critical illness benefit received by a company is generally considered non-taxable, but no specific tax rule governs it. Unlike a life insurance death benefit, it is not credited to the Capital Dividend Account (CDA): if the company then pays it to shareholders, it will generally be a taxable dividend. Alexandre coordinates with your accountant based on your structure.

It depends on the structure of your leadership team. In a company with two partners, it often makes sense to cover both. For a business that depends on a sales director, a targeted key person policy may be enough. Alexandre analyzes the vulnerability of each role.

Yes. Once paid, the capital from a company-owned critical illness policy can generally be used freely. The company can allocate it to its needs: replacement, debt, projects, or a cash reserve.

The same as personal policies of the same product, for example cancer, heart attack, stroke, organ transplant or multiple sclerosis, as defined in the contract. The number of illnesses covered varies by product.

Generally, no: a critical illness premium paid by the company is not deductible. If the company pays the premium on a policy whose beneficiary is a shareholder or employee, it may create a taxable benefit for that person. The tax treatment depends on your structure, to confirm with your accountant.

Yes, the survival period set out in the contract also applies (often 30 days after diagnosis). Alexandre checks the specific clauses for the product chosen for your business.

The policy can be transferred to the person, cancelled, or reassigned to a new key leader. A transfer can have tax consequences. Alexandre reviews the structure whenever the leadership team changes.